Contact, publication, and social network information about Harvard faculty and fellows. Harvard Catalyst Profiles
Keywords
Last Name
Institution

profileAshwin N Ananthakrishnan, M.B.,B.S.

TitleAssistant Professor of Medicine
InstitutionMassachusetts General Hospital
DepartmentMedicine
AddressMassachusetts General Hospital
9th Flr
165 Cambridge St
Boston MA 02114
Phone617/724-6005
Fax617/726-3080
vCardDownload vCard (login for email)

Collapse Research 
Collapse research activities and funding
The research activities and funding listed below are automatically derived from NIH ExPORTER and other sources, which might result in incorrect or missing items. Faculty can login to make corrections and additions.
K23DK097142     (ANANTHAKRISHNAN, ASHWIN N)Sep 15, 2012 - May 31, 2017
NIH/NIDDK
Genetic predictors of anti-TNF treatment response and infections in IBD
Role: Principal Investigator

Collapse Bibliographic 
Collapse selected publications
Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
List All   |   Timeline
  1. Sasidharan S, Yajnik V, Khalili H, Garber J, Xavier R, Ananthakrishnan AN. Genetic risk factors for serious infections in inflammatory bowel diseases. Scand J Gastroenterol. 2017 May; 52(5):570-576. PMID: 28162010.
    View in: PubMed
  2. Borren N, Goel G, Lassen K, Devaney K, Cleland T, Garber J, Khalili H, Yajnik V, Xavier R, Ananthakrishnan A. P023 Fatigue in quiescent inflammatory bowel disease is associated with low GM-CSF levels and metabolomic alterations. J Crohns Colitis. 2017 Feb 01; 11(suppl_1):S91-S92. PMID: 28174948.
    View in: PubMed
  3. Chen Y, Furuya-Kanamori L, Doi SA, Ananthakrishnan AN, Kirk M. Clostridium difficile Infection and Risk of Colectomy in Patients with Inflammatory Bowel Disease: A Bias-adjusted Meta-analysis. Inflamm Bowel Dis. 2017 Feb; 23(2):200-207. PMID: 28079620.
    View in: PubMed
  4. Velonias G, Conway G, Andrews E, Garber JJ, Khalili H, Yajnik V, Ananthakrishnan AN. Older Age- and Health-related Quality of Life in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2017 Feb; 23(2):283-288. PMID: 28079625.
    View in: PubMed
  5. Borren N, Conway G, Garber J, Khalili H, Yajnik V, Xavier R, Ananthakrishnan A. P688 Crohn's disease patients with a concordant family history are diagnosed earlier and are at increased risk for complicated disease. J Crohns Colitis. 2017 Feb 01; 11(suppl_1):S431-S432. PMID: 28172996.
    View in: PubMed
  6. Borren N, Tan W, Andrews E, Khalili H, Garber J, Yajnik V, Ananthakrishnan A. P704 The impact of travel distance on disease outcomes in inflammatory bowel disease. J Crohns Colitis. 2017 Feb 01; 11(suppl_1):S441. PMID: 28175236.
    View in: PubMed
  7. Stevens BW, Borren NZ, Velonias G, Conway G, Cleland T, Andrews E, Khalili H, Garber JJ, Xavier RJ, Yajnik V, Ananthakrishnan AN. Erratum to: Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci. 2017 Feb; 62(2):552. PMID: 27864657.
    View in: PubMed
  8. Singh P, Ananthakrishnan A, Ahuja V. Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017 Jan; 15(1):138-141. PMID: 28239326.
    View in: PubMed
  9. Conway G, Velonias G, Andrews E, Garber JJ, Yajnik V, Ananthakrishnan AN. The impact of co-existing immune-mediated diseases on phenotype and outcomes in inflammatory bowel diseases. Aliment Pharmacol Ther. 2017 Mar; 45(6):814-823. PMID: 28105709.
    View in: PubMed
  10. Staller K, Barshop K, Kuo B, Ananthakrishnan AN. Depression but Not Symptom Severity is Associated With Work and School Absenteeism in Refractory Chronic Constipation. J Clin Gastroenterol. 2017 Jan 05. PMID: 28059936.
    View in: PubMed
  11. Van Der Sloot KW, Joshi AD, Bellavance DR, Gilpin KK, Stewart KO, Lochhead P, Garber JJ, Giallourakis C, Yajnik V, Ananthakrishnan AN, Alizadeh BZ, Xavier RJ, Khalili H. Visceral Adiposity, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2017 Jan; 23(1):82-88. PMID: 27893544.
    View in: PubMed
  12. Ananthakrishnan AN. Filgotinib for Crohn's disease-expanding treatment options. Lancet. 2017 Jan 21; 389(10066):228-229. PMID: 27988141.
    View in: PubMed
  13. Khalili H, Malik S, Ananthakrishnan AN, Garber JJ, Higuchi LM, Joshi A, Peloquin J, Richter JM, Stewart KO, Curhan GC, Awasthi A, Yajnik V, Chan AT. Identification and Characterization of a Novel Association between Dietary Potassium and Risk of Crohn's Disease and Ulcerative Colitis. Front Immunol. 2016; 7:554. PMID: 28003811.
    View in: PubMed
  14. Shelton E, Ananthakrishnan AN. Reply. Gastroenterology. 2017 Jan; 152(1):306. PMID: 27893976.
    View in: PubMed
  15. Mao EJ, Hazlewood GS, Kaplan GG, Peyrin-Biroulet L, Ananthakrishnan AN. Systematic review with meta-analysis: comparative efficacy of immunosuppressants and biologics for reducing hospitalisation and surgery in Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther. 2017 Jan; 45(1):3-13. PMID: 27862107.
    View in: PubMed
  16. Rodrigues R, Barber GE, Ananthakrishnan AN. A Comprehensive Study of Costs Associated With Recurrent Clostridium difficile Infection. Infect Control Hosp Epidemiol. 2017 Feb; 38(2):196-202. PMID: 27817758.
    View in: PubMed
  17. Pratap Mouli V, Munot K, Ananthakrishnan A, Kedia S, Addagalla S, Garg SK, Benjamin J, Singla V, Dhingra R, Tiwari V, Bopanna S, Hutfless S, Makharia G, Ahuja V. Endoscopic and clinical responses to anti-tubercular therapy can differentiate intestinal tuberculosis from Crohn's disease. Aliment Pharmacol Ther. 2017 Jan; 45(1):27-36. PMID: 27813111.
    View in: PubMed
  18. Stevens BW, Borren NZ, Velonias G, Conway G, Cleland T, Andrews E, Khalili H, Garber JG, Xavier RJ, Yajnik V, Ananthakrishnan AN. Vedolizumab Therapy Is Associated with an Improvement in Sleep Quality and Mood in Inflammatory Bowel Diseases. Dig Dis Sci. 2017 Jan; 62(1):197-206. PMID: 27796768.
    View in: PubMed
  19. Yu S, Chakrabortty A, Liao KP, Cai T, Ananthakrishnan AN, Gainer VS, Churchill SE, Szolovits P, Murphy SN, Kohane IS, Cai T. Surrogate-assisted feature extraction for high-throughput phenotyping. J Am Med Inform Assoc. 2016 Sep 15. PMID: 27632993.
    View in: PubMed
  20. Rivas MA, Graham D, Sulem P, Stevens C, Desch AN, Goyette P, Gudbjartsson D, Jonsdottir I, Thorsteinsdottir U, Degenhardt F, Mucha S, Kurki MI, Li D, D'Amato M, Annese V, Vermeire S, Weersma RK, Halfvarson J, Paavola-Sakki P, Lappalainen M, Lek M, Cummings B, Tukiainen T, Haritunians T, Halme L, Koskinen LL, Ananthakrishnan AN, Luo Y, Heap GA, Visschedijk MC, MacArthur DG, Neale BM, Ahmad T, Anderson CA, Brant SR, Duerr RH, Silverberg MS, Cho JH, Palotie A, Saavalainen P, Kontula K, Färkkilä M, McGovern DP, Franke A, Stefansson K, Rioux JD, Xavier RJ, Daly MJ. Erratum: A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat Commun. 2016 Sep 13; 7:12869. PMID: 27619887; PMCID: PMC5027274.
  21. Barber GE, Yajnik V, Khalili H, Giallourakis C, Garber J, Xavier R, Ananthakrishnan AN. Genetic Markers Predict Primary Non-Response and Durable Response To Anti-TNF Biologic Therapies in Crohn's Disease. Am J Gastroenterol. 2016 Dec; 111(12):1816-1822. PMID: 27596696.
    View in: PubMed
  22. Cholapranee A, Ananthakrishnan AN. Environmental Hygiene and Risk of Inflammatory Bowel Diseases: A Systematic Review and Meta-analysis. Inflamm Bowel Dis. 2016 Sep; 22(9):2191-9. PMID: 27482977; PMCID: PMC4992453 [Available on 09/01/17].
  23. Law CC, Sasidharan S, Rodrigues R, Nguyen DD, Sauk J, Garber J, Giallourakis C, Xavier R, Khalili H, Yajnik V, Ananthakrishnan AN. Impact of Specialized Inpatient IBD Care on Outcomes of IBD Hospitalizations: A Cohort Study. Inflamm Bowel Dis. 2016 Sep; 22(9):2149-57. PMID: 27482978; PMCID: PMC4992425 [Available on 09/01/17].
  24. Rivas MA, Graham D, Sulem P, Stevens C, Desch AN, Goyette P, Gudbjartsson D, Jonsdottir I, Thorsteinsdottir U, Degenhardt F, Mucha S, Kurki MI, Li D, D'Amato M, Annese V, Vermeire S, Weersma RK, Halfvarson J, Paavola-Sakki P, Lappalainen M, Lek M, Cummings B, Tukiainen T, Haritunians T, Halme L, Koskinen LL, Ananthakrishnan AN, Luo Y, Heap GA, Visschedijk MC, MacArthur DG, Neale BM, Ahmad T, Anderson CA, Brant SR, Duerr RH, Silverberg MS, Cho JH, Palotie A, Saavalainen P, Kontula K, Färkkilä M, McGovern DP, Franke A, Stefansson K, Rioux JD, Xavier RJ, Daly MJ, Barrett J, de Lane K, Edwards C, Hart A, Hawkey C, Jostins L, Kennedy N, Lamb C, Lee J, Lees C, Mansfield J, Mathew C, Mowatt C, Newman B, Nimmo E, Parkes M, Pollard M, Prescott N, Randall J, Rice D, Satsangi J, Simmons A, Tremelling M, Uhlig H, Wilson D, Abraham C, Achkar JP, Bitton A, Boucher G, Croitoru K, Fleshner P, Glas J, Kugathasan S, Limbergen JV, Milgrom R, Proctor D, Regueiro M, Schumm PL, Sharma Y, Stempak JM, Targan SR, Wang MH. A protein-truncating R179X variant in RNF186 confers protection against ulcerative colitis. Nat Commun. 2016 Aug 09; 7:12342. PMID: 27503255; PMCID: PMC4980482.
  25. Rajbhandari R, Simon RE, Chung RT, Ananthakrishnan AN. Racial Disparities in Inhospital Outcomes for Hepatocellular Carcinoma in the United States. Mayo Clin Proc. 2016 Sep; 91(9):1173-82. PMID: 27497857.
    View in: PubMed
  26. Li D, Achkar JP, Haritunians T, Jacobs JP, Hui KY, D'Amato M, Brand S, Radford-Smith G, Halfvarson J, Niess JH, Kugathasan S, Büning C, Schumm LP, Klei L, Ananthakrishnan A, Aumais G, Baidoo L, Dubinsky M, Fiocchi C, Glas J, Milgrom R, Proctor DD, Regueiro M, Simms LA, Stempak JM, Targan SR, Törkvist L, Sharma Y, Devlin B, Borneman J, Hakonarson H, Xavier RJ, Daly M, Brant SR, Rioux JD, Silverberg MS, Cho JH, Braun J, McGovern DP, Duerr RH. A Pleiotropic Missense Variant in SLC39A8 Is Associated With Crohn's Disease and Human Gut Microbiome Composition. Gastroenterology. 2016 Oct; 151(4):724-32. PMID: 27492617; PMCID: PMC5037008 [Available on 10/01/17].
  27. Ananthakrishnan AN. Vitamin D and Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2016 Aug; 12(8):513-515. PMID: 27917088.
    View in: PubMed
  28. Kisiel JB, Konijeti GG, Piscitello AJ, Chandra T, Goss TF, Ahlquist DA, Farraye FA, Ananthakrishnan AN. Stool DNA Analysis is Cost-Effective for Colorectal Cancer Surveillance in Patients With Ulcerative Colitis. Clin Gastroenterol Hepatol. 2016 Dec; 14(12):1778-1787.e8. PMID: 27464589.
    View in: PubMed
  29. Cohen BL, Ha C, Ananthakrishnan AN, Rieder F, Bewtra M. State of Adult Trainee Inflammatory Bowel Disease Education in the United States: A National Survey. Inflamm Bowel Dis. 2016 Jul; 22(7):1609-15. PMID: 27306068; PMCID: PMC4911816 [Available on 07/01/17].
  30. Rajbhandari R, Jun T, Khalili H, Chung RT, Ananthakrishnan AN. HBV/HIV coinfection is associated with poorer outcomes in hospitalized patients with HBV or HIV. J Viral Hepat. 2016 Oct; 23(10):820-9. PMID: 27291562.
    View in: PubMed
  31. Rieder F, Cohen BL, Dotson JL, Bewtra M, Ananthakrishnan AN, Falaiye TO, Ha CY. Rising Educators, Academicians, and Clinicians Helping Inflammatory Bowel Disease (REACH-IBD)-Promoting Improvement of Inflammatory Bowel Disease Education in the United States. Inflamm Bowel Dis. 2016 Jun; 22(6):1531-2. PMID: 27167574; PMCID: PMC4870172 [Available on 06/01/17].
  32. Song M, Konijeti GG, Yuan C, Ananthakrishnan AN, Ogino S, Fuchs CS, Giovannucci EL, Ng K, Chan AT. Plasma 25-Hydroxyvitamin D, Vitamin D Binding Protein, and Risk of Colorectal Cancer in the Nurses' Health Study. Cancer Prev Res (Phila). 2016 Aug; 9(8):664-72. PMID: 27246684; PMCID: PMC4970876 [Available on 08/01/17].
  33. Pedamallu CS, Bhatt AS, Bullman S, Fowler S, Freeman SS, Durand J, Jung J, Duke F, Manzo V, Cai D, Ananthakrishnan A, Ojesina AI, Ramachandran A, Gevers D, Xavier RJ, Bhan AK, Meyerson M, Yajnik V. Metagenomic Characterization of Microbial Communities In Situ Within the Deeper Layers of the Ileum in Crohn's Disease. Cell Mol Gastroenterol Hepatol. 2016 Sep; 2(5):563-566.e5. PMID: 28174737.
    View in: PubMed
  34. Taleban S, Stewart KO, Li DK, Singh P, Pardi DS, Sturgeon HC, Yajnik V, Xavier RJ, Ananthakrishnan AN, Khalili H. Clinical Activity and Quality of Life Indices Are Valid Across Ulcerative Colitis But Not Crohn's Disease Phenotypes. Dig Dis Sci. 2016 Sep; 61(9):2627-35. PMID: 27142671; PMCID: PMC4982770 [Available on 09/01/17].
  35. Ananthakrishnan AN. Editorial: Vitamin D and IBD: Can We Get Over the "Causation" Hump? Am J Gastroenterol. 2016 May; 111(5):720-2. PMID: 27151121.
    View in: PubMed
  36. Shelton E, Laharie D, Scott FI, Mamtani R, Lewis JD, Colombel JF, Ananthakrishnan AN. Cancer Recurrence Following Immune-Suppressive Therapies in Patients With Immune-Mediated Diseases: A Systematic Review and Meta-analysis. Gastroenterology. 2016 Jul; 151(1):97-109.e4. PMID: 27039969; PMCID: PMC4925196 [Available on 07/01/17].
  37. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Savova G, Churchill S, Karlson EW, Kohane I, Liao KP, Murphy SN. Comparative Effectiveness of Infliximab and Adalimumab in Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2016 Apr; 22(4):880-5. PMID: 26933751; PMCID: PMC4792716 [Available on 04/01/17].
  38. Rajbhandari R, Barton K, Juncadella AC, Rubin AK, Ajayi T, Wu Y, Ananthakrishnan AN, Chung RT. Discontinuity of care for mothers with chronic hepatitis B diagnosed during pregnancy. J Viral Hepat. 2016 Jul; 23(7):561-8. PMID: 26940754.
    View in: PubMed
  39. Ananthakrishnan AN, Shi HY, Tang W, Law CC, Sung JJ, Chan FK, Ng SC. Systematic Review and Meta-analysis: Phenotype and Clinical Outcomes of Older-onset Inflammatory Bowel Disease. J Crohns Colitis. 2016 Oct; 10(10):1224-36. PMID: 26928965.
    View in: PubMed
  40. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Liao KP, Kohane I. Statin Use Is Associated With Reduced Risk of Colorectal Cancer in Patients With Inflammatory Bowel Diseases. Clin Gastroenterol Hepatol. 2016 Jul; 14(7):973-9. PMID: 26905907; PMCID: PMC4912917 [Available on 07/01/17].
  41. Kassam Z, Cribb Fabersunne C, Smith MB, Alm EJ, Kaplan GG, Nguyen GC, Ananthakrishnan AN. Clostridium difficile associated risk of death score (CARDS): a novel severity score to predict mortality among hospitalised patients with C. difficile infection. Aliment Pharmacol Ther. 2016 Mar; 43(6):725-33. PMID: 26849527.
    View in: PubMed
  42. Lochhead P, Khalili H, Ananthakrishnan AN, Richter JM, Chan AT. Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease. Clin Gastroenterol Hepatol. 2016 Jun; 14(6):818-824.e6. PMID: 26844874; PMCID: PMC4875875 [Available on 06/01/17].
  43. Vedak P, Kroshinsky D, St John J, Xavier RJ, Yajnik V, Ananthakrishnan AN. Genetic basis of TNF-a antagonist associated psoriasis in inflammatory bowel diseases: a genotype-phenotype analysis. Aliment Pharmacol Ther. 2016 Mar; 43(6):697-704. PMID: 26806281; PMCID: PMC4755796 [Available on 03/01/17].
  44. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Savova G, Churchill S, Karlson EW, Murphy SN, Liao KP, Kohane I. Identification of Nonresponse to Treatment Using Narrative Data in an Electronic Health Record Inflammatory Bowel Disease Cohort. Inflamm Bowel Dis. 2016 Jan; 22(1):151-8. PMID: 26332313; PMCID: PMC4772891 [Available on 01/01/17].
  45. Kane SV, Ananthakrishnan AN. Toward reducing bias in clinical trials: central readers for endoscopic endpoints. Gastrointest Endosc. 2016 Jan; 83(1):198-200. PMID: 26706305.
    View in: PubMed
  46. Peloquin JM, Seraj SM, King LY, Campbell EJ, Ananthakrishnan AN, Richter JM. Diagnostic and Therapeutic Yield of Endoscopy in Patients with Elevated INR and Gastrointestinal Bleeding. Am J Med. 2016 Jun; 129(6):628-34. PMID: 26714209.
    View in: PubMed
  47. Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Chan AT. Zinc intake and risk of Crohn’s disease and ulcerative colitis: a prospective cohort study. Int J Epidemiol. 2015 Dec; 44(6):1995-2005. PMID: 26546032.
    View in: PubMed
  48. Shelton E, Allegretti JR, Stevens B, Lucci M, Khalili H, Nguyen DD, Sauk J, Giallourakis C, Garber J, Hamilton MJ, Tomczak M, Makrauer F, Burakoff RB, Levine J, de Silva P, Friedman S, Ananthakrishnan A, Korzenik JR, Yajnik V. Efficacy of Vedolizumab as Induction Therapy in Refractory IBD Patients: A Multicenter Cohort. Inflamm Bowel Dis. 2015 Dec; 21(12):2879-85. PMID: 26288002; PMCID: PMC4745906 [Available on 12/01/16].
  49. Gupta V, Rodrigues R, Nguyen D, Sauk J, Khalili H, Yajnik V, Ananthakrishnan AN. Adjuvant use of antibiotics with corticosteroids in inflammatory bowel disease exacerbations requiring hospitalisation: a retrospective cohort study and meta-analysis. Aliment Pharmacol Ther. 2016 Jan; 43(1):52-60. PMID: 26541937; PMCID: PMC4673010 [Available on 01/01/17].
  50. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP, Xavier RJ. Common Genetic Variants Influence Circulating Vitamin D Levels in Inflammatory Bowel Diseases. Inflamm Bowel Dis. 2015 Nov; 21(11):2507-14. PMID: 26241000; PMCID: PMC4615315 [Available on 11/01/16].
  51. Walker AM, Zhou X, Ananthakrishnan AN, Weiss LS, Shen R, Sobel RE, Bate A, Reynolds RF. Computer-assisted expert case definition in electronic health records. Int J Med Inform. 2016 Feb; 86:62-70. PMID: 26725697.
    View in: PubMed
  52. Ananthakrishnan A, Shankar M, Chahar A, Kachroo K, Ameel M, Sharma J, Vsn M, Dang A. The Use of Mobile Health Technology in Promoting Infant Vaccine Adherence - A Health Technology Assessment. Value Health. 2015 Nov; 18(7):A559. PMID: 26533141.
    View in: PubMed
  53. Ananthakrishnan AN, Khalili H, Song M, Higuchi LM, Richter JM, Nimptsch K, Wu K, Chan AT. High School Diet and Risk of Crohn's Disease and Ulcerative Colitis. Inflamm Bowel Dis. 2015 Oct; 21(10):2311-9. PMID: 26236952; PMCID: PMC4567521 [Available on 10/01/16].
  54. Pringle PL, Stewart KO, Peloquin JM, Sturgeon HC, Nguyen D, Sauk J, Garber JJ, Yajnik V, Ananthakrishnan AN, Chan AT, Xavier RJ, Khalili H. Body Mass Index, Genetic Susceptibility, and Risk of Complications Among Individuals with Crohn's Disease. Inflamm Bowel Dis. 2015 Oct; 21(10):2304-10. PMID: 26181430; PMCID: PMC4567407 [Available on 10/01/16].
  55. Ananthakrishnan AN. Chromoendoscopy Is Better: So Why Am I Not (yet) Using it for Routine Inflammatory Bowel Disease Surveillance? Clin Gastroenterol Hepatol. 2016 May; 14(5):720-2. PMID: 26407751; PMCID: PMC4808481 [Available on 05/01/17].
  56. Liao KP, Ananthakrishnan AN, Kumar V, Xia Z, Cagan A, Gainer VS, Goryachev S, Chen P, Savova GK, Agniel D, Churchill S, Lee J, Murphy SN, Plenge RM, Szolovits P, Kohane I, Shaw SY, Karlson EW, Cai T. Methods to Develop an Electronic Medical Record Phenotype Algorithm to Compare the Risk of Coronary Artery Disease across 3 Chronic Disease Cohorts. PLoS One. 2015; 10(8):e0136651. PMID: 26301417; PMCID: PMC4547801.
  57. Axelrad J, Bernheim O, Colombel JF, Malerba S, Ananthakrishnan A, Yajnik V, Hoffman G, Agrawal M, Lukin D, Desai A, McEachern E, Bosworth B, Scherl E, Reyes A, Zaidi H, Mudireddy P, DiCaprio D, Sultan K, Korelitz B, Wang E, Williams R, Chen L, Katz S, Itzkowitz S. Risk of New or Recurrent Cancer in Patients With Inflammatory Bowel Disease and Previous Cancer Exposed to Immunosuppressive and Anti-Tumor Necrosis Factor Agents. Clin Gastroenterol Hepatol. 2016 Jan; 14(1):58-64. PMID: 26247164.
    View in: PubMed
  58. Staller K, Barshop K, Kuo B, Ananthakrishnan AN. Resting anal pressure, not outlet obstruction or transit, predicts healthcare utilization in chronic constipation: a retrospective cohort analysis. Neurogastroenterol Motil. 2015 Oct; 27(10):1378-88. PMID: 26172284; PMCID: PMC4584201 [Available on 10/01/16].
  59. Ananthakrishnan AN. Editorial: diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases - author's reply. Aliment Pharmacol Ther. 2015 Jul; 42(1):120. PMID: 26040521.
    View in: PubMed
  60. Ananthakrishnan AN, Lieberman D. Patient Electronic Health Records as a Means to Approach Genetic Research in Gastroenterology. Gastroenterology. 2015 Oct; 149(5):1134-7. PMID: 26073373; PMCID: PMC4589451 [Available on 10/01/16].
  61. Khalili H, Ananthakrishnan AN, Konijeti GG, Higuchi LM, Fuchs CS, Richter JM, Tworoger SS, Hankinson SE, Chan AT. Endogenous levels of circulating androgens and risk of Crohn's disease and ulcerative colitis among women: a nested case-control study from the nurses' health study cohorts. Inflamm Bowel Dis. 2015 Jun; 21(6):1378-85. PMID: 25844961; PMCID: PMC4437806.
  62. Staller K, Barshop K, Ananthakrishnan AN, Kuo B. Rectosigmoid Localization of Radiopaque Markers Does Not Correlate with Prolonged Balloon Expulsion in Chronic Constipation: Results from a Multicenter Cohort. Am J Gastroenterol. 2015 Jul; 110(7):1049-55. PMID: 25964224.
    View in: PubMed
  63. Ananthakrishnan AN. Reply: To PMID 25041865. Clin Gastroenterol Hepatol. 2015 Sep; 13(9):1703-4. PMID: 25970734.
    View in: PubMed
  64. Wen J, Barber GE, Ananthakrishnan AN. Identification of Recurrent Clostridium difficile Infection Using Administrative Codes: Accuracy and Implications for Surveillance. Infect Control Hosp Epidemiol. 2015 Aug; 36(8):893-8. PMID: 25924718.
    View in: PubMed
  65. Liao KP, Cai T, Savova GK, Murphy SN, Karlson EW, Ananthakrishnan AN, Gainer VS, Shaw SY, Xia Z, Szolovits P, Churchill S, Kohane I. Development of phenotype algorithms using electronic medical records and incorporating natural language processing. BMJ. 2015 Apr 24; 350:h1885. PMID: 25911572; PMCID: PMC4707569.
  66. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Diabetes and the risk of infections with immunomodulator therapy in inflammatory bowel diseases. Aliment Pharmacol Ther. 2015 Jun; 41(11):1141-8. PMID: 25864945; PMCID: PMC4420684.
  67. Ananthakrishnan AN, Kane SV. The Toronto consensus guidelines for nonhospitalized ulcerative colitis: a welcome update but not the end of the story. Gastroenterology. 2015 May; 148(5):877-80. PMID: 25805424.
    View in: PubMed
  68. Rajbhandari R, Danford CJ, Chung RT, Ananthakrishnan AN. HBV infection is associated with greater mortality in hospitalised patients compared to HCV infection or alcoholic liver disease. Aliment Pharmacol Ther. 2015 May; 41(10):928-38. PMID: 25786514.
    View in: PubMed
  69. Shelton E, Chaudrey K, Sauk J, Khalili H, Masia R, Nguyen DD, Yajnik V, Ananthakrishnan AN. New onset idiosyncratic liver enzyme elevations with biological therapy in inflammatory bowel disease. Aliment Pharmacol Ther. 2015 May; 41(10):972-9. PMID: 25756190.
    View in: PubMed
  70. Ananthakrishnan AN. Epidemiology and risk factors for IBD. Nat Rev Gastroenterol Hepatol. 2015 Apr; 12(4):205-17. PMID: 25732745.
    View in: PubMed
  71. Wilson RG, Stevens BW, Guo AY, Russell CN, Thornton A, Cohen MA, Sturgeon HC, Giallourakis C, Khalili H, Nguyen DD, Yajnik V, Sauk J, Ananthakrishnan AN. High C-Reactive Protein Is Associated with Poor Sleep Quality Independent of Nocturnal Symptoms in Patients with Inflammatory Bowel Disease. Dig Dis Sci. 2015 Jul; 60(7):2136-43. PMID: 25701321; PMCID: PMC4466073.
  72. Khalili H, Ananthakrishnan AN, Konijeti GG, Higuchi LM, Fuchs CS, Richter JM, Chan AT. Measures of obesity and risk of Crohn's disease and ulcerative colitis. Inflamm Bowel Dis. 2015 Feb; 21(2):361-8. PMID: 25563694; PMCID: PMC4308549.
  73. Ananthakrishnan AN. Reply: To PMID 24161349. Clin Gastroenterol Hepatol. 2015 Apr; 13(4):814. PMID: 25576688.
    View in: PubMed
  74. Ananthakrishnan AN. Surgery for Crohn's disease: look harder, act faster. Lancet. 2015 Apr 11; 385(9976):1370-1. PMID: 25542619.
    View in: PubMed
  75. Guo AY, Stevens BW, Wilson RG, Russell CN, Cohen MA, Sturgeon HC, Thornton A, Giallourakis C, Khalili H, Nguyen DD, Sauk J, Yajnik V, Xavier RJ, Ananthakrishnan AN. Early life environment and natural history of inflammatory bowel diseases. BMC Gastroenterol. 2014 Dec 16; 14:216. PMID: 25510175; PMCID: PMC4300207.
  76. Sahay T, Ananthakrishnan AN. Vitamin D deficiency is associated with community-acquired clostridium difficile infection: a case-control study. BMC Infect Dis. 2014 Dec 04; 14:661. PMID: 25471926; PMCID: PMC4258019.
  77. Sauk J, Nguyen D, Yajnik V, Khalili H, Konijeti G, Hodin R, Bordeianou L, Shellito P, Sylla P, Korzenik J, Friedman S, Ananthakrishnan AN. Natural history of perianal Crohn's disease after fecal diversion. Inflamm Bowel Dis. 2014 Dec; 20(12):2260-5. PMID: 25230164.
    View in: PubMed
  78. Ananthakrishnan AN, Hanauer SB. The Holy Grail, or only half way there? Gastroenterology. 2015 Jan; 148(1):8-10. PMID: 25451664.
    View in: PubMed
  79. Ananthakrishnan AN, Kwon J, Raffals L, Sands B, Stenson WF, McGovern D, Kwon JH, Rheaume RL, Sandler RS. Variation in treatment of patients with inflammatory bowel diseases at major referral centers in the United States. Clin Gastroenterol Hepatol. 2015 Jun; 13(6):1197-200. PMID: 25460565; PMCID: PMC4440845.
  80. Ananthakrishnan AN. Reply: To PMID 24088707. JPEN J Parenter Enteral Nutr. 2014 Nov; 38(8):925. PMID: 25342587.
    View in: PubMed
  81. Ananthakrishnan AN, Du M, Berndt SI, Brenner H, Caan BJ, Casey G, Chang-Claude J, Duggan D, Fuchs CS, Gallinger S, Giovannucci EL, Harrison TA, Hayes RB, Hoffmeister M, Hopper JL, Hou L, Hsu L, Jenkins MA, Kraft P, Ma J, Nan H, Newcomb PA, Ogino S, Potter JD, Seminara D, Slattery ML, Thornquist M, White E, Wu K, Peters U, Chan AT. Red meat intake, NAT2, and risk of colorectal cancer: a pooled analysis of 11 studies. Cancer Epidemiol Biomarkers Prev. 2015 Jan; 24(1):198-205. PMID: 25342387; PMCID: PMC4294960 [Available on 01/01/16].
  82. Ananthakrishnan AN, Cheng A, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Mode of childbirth and long-term outcomes in women with inflammatory bowel diseases. Dig Dis Sci. 2015 Feb; 60(2):471-7. PMID: 25213079; PMCID: PMC4304947.
  83. Ananthakrishnan AN. Environmental risk factors for inflammatory bowel diseases: a review. Dig Dis Sci. 2015 Feb; 60(2):290-8. PMID: 25204669; PMCID: PMC4304948.
  84. Castro VM, Apperson WK, Gainer VS, Ananthakrishnan AN, Goodson AP, Wang TD, Herrick CD, Murphy SN. Evaluation of matched control algorithms in EHR-based phenotyping studies: a case study of inflammatory bowel disease comorbidities. J Biomed Inform. 2014 Dec; 52:105-11. PMID: 25196084; PMCID: PMC4261034.
  85. Hohmann EL, Ananthakrishnan AN, Deshpande V. Case Records of the Massachusetts General Hospital. Case 25-2014. A 37-year-old man with ulcerative colitis and bloody diarrhea. N Engl J Med. 2014 Aug 14; 371(7):668-75. PMID: 25119613.
    View in: PubMed
  86. Cheng AG, Oxford EC, Sauk J, Nguyen DD, Yajnik V, Friedman S, Ananthakrishnan AN. Impact of mode of delivery on outcomes in patients with perianal Crohn's disease. Inflamm Bowel Dis. 2014 Aug; 20(8):1391-8. PMID: 24918322; PMCID: PMC4104983.
  87. Sinnott JA, Dai W, Liao KP, Shaw SY, Ananthakrishnan AN, Gainer VS, Karlson EW, Churchill S, Szolovits P, Murphy S, Kohane I, Plenge R, Cai T. Improving the power of genetic association tests with imperfect phenotype derived from electronic medical records. Hum Genet. 2014 Nov; 133(11):1369-82. PMID: 25062868; PMCID: PMC4185241.
  88. Ananthakrishnan AN, Cagan A, Cai T, Gainer VS, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Colonoscopy is associated with a reduced risk for colon cancer and mortality in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2015 Feb; 13(2):322-329.e1. PMID: 25041865; PMCID: PMC4297589.
  89. Ananthakrishnan AN. The exposome in inflammatory bowel disease. Trop Gastroenterol. 2014 Jul-Sep; 35(3):135-40. PMID: 26012316.
    View in: PubMed
  90. Lopez J, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Natural history of Crohn's disease following total colectomy and end ileostomy. Inflamm Bowel Dis. 2014 Jul; 20(7):1236-41. PMID: 24859297; PMCID: PMC4065414.
  91. Ananthakrishnan AN, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Genetic polymorphisms in metabolizing enzymes modifying the association between smoking and inflammatory bowel diseases. Inflamm Bowel Dis. 2014 May; 20(5):783-9. PMID: 24651583; PMCID: PMC4113010.
  92. Ananthakrishnan AN. Reply: To PMID 24703865. Clin Gastroenterol Hepatol. 2014 Sep; 12(9):1577-8. PMID: 24793024.
    View in: PubMed
  93. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Richter JM, Schernhammer ES, Chan AT. Sleep duration affects risk for ulcerative colitis: a prospective cohort study. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1879-86. PMID: 24780288; PMCID: PMC4209312.
  94. Scoville EA, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Venous thromboembolism in patients with inflammatory bowel diseases: a case-control study of risk factors. Inflamm Bowel Dis. 2014 Apr; 20(4):631-6. PMID: 24552828; PMCID: PMC4116613.
  95. Konijeti GG, Sauk J, Shrime MG, Gupta M, Ananthakrishnan AN. Cost-effectiveness of competing strategies for management of recurrent Clostridium difficile infection: a decision analysis. Clin Infect Dis. 2014 Jun; 58(11):1507-14. PMID: 24692533; PMCID: PMC4017891.
  96. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Higher plasma vitamin D is associated with reduced risk of Clostridium difficile infection in patients with inflammatory bowel diseases. Aliment Pharmacol Ther. 2014 May; 39(10):1136-42. PMID: 24641590; PMCID: PMC4187206.
  97. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Scoville E, Konijeti GG, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Thromboprophylaxis is associated with reduced post-hospitalization venous thromboembolic events in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014 Nov; 12(11):1905-10. PMID: 24632349; PMCID: PMC4162859.
  98. Ananthakrishnan AN, Chan AT. Reply: To PMID 23912083. Gastroenterology. 2014 Apr; 146(4):1134-5. PMID: 24576728.
    View in: PubMed
  99. Ananthakrishnan AN, Cagan A, Gainer VS, Cheng SC, Cai T, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Mortality and extraintestinal cancers in patients with primary sclerosing cholangitis and inflammatory bowel disease. J Crohns Colitis. 2014 Sep; 8(9):956-63. PMID: 24559536; PMCID: PMC4136996.
  100. Long MD, Hutfless S, Kappelman MD, Khalili H, Kaplan GG, Bernstein CN, Colombel JF, Gower-Rousseau C, Herrinton L, Velayos F, Loftus EV, Nguyen GC, Ananthakrishnan AN, Sonnenberg A, Chan A, Sandler RS, Atreja A, Shah SA, Rothman KJ, Leleiko NS, Bright R, Boffetta P, Myers KD, Sands BE. Challenges in designing a national surveillance program for inflammatory bowel disease in the United States. Inflamm Bowel Dis. 2014 Feb; 20(2):398-415. PMID: 24280882; PMCID: PMC4610029.
  101. Fowler SA, Ananthakrishnan AN, Gardet A, Stevens CR, Korzenik JR, Sands BE, Daly MJ, Xavier RJ, Yajnik V. SMAD3 gene variant is a risk factor for recurrent surgery in patients with Crohn's disease. J Crohns Colitis. 2014 Aug; 8(8):845-51. PMID: 24461721; PMCID: PMC4237062.
  102. Ananthakrishnan AN, Huang H, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Differential effect of genetic burden on disease phenotypes in Crohn's disease and ulcerative colitis: analysis of a North American cohort. Am J Gastroenterol. 2014 Mar; 109(3):395-400. PMID: 24419484; PMCID: PMC4225079.
  103. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Serum inflammatory markers and risk of colorectal cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014 Aug; 12(8):1342-8.e1. PMID: 24407106; PMCID: PMC4085150.
  104. Konijeti GG, Shrime MG, Ananthakrishnan AN, Chan AT. Cost-effectiveness analysis of chromoendoscopy for colorectal cancer surveillance in patients with ulcerative colitis. Gastrointest Endosc. 2014 Mar; 79(3):455-65. PMID: 24262637; PMCID: PMC4116277.
  105. Mouli VP, Ananthakrishnan AN. Review article: vitamin D and inflammatory bowel diseases. Aliment Pharmacol Ther. 2014 Jan; 39(2):125-36. PMID: 24236989; PMCID: PMC3872479.
  106. Khalili H, Ananthakrishnan AN, Konijeti GG, Liao X, Higuchi LM, Fuchs CS, Spiegelman D, Richter JM, Korzenik JR, Chan AT. Physical activity and risk of inflammatory bowel disease: prospective study from the Nurses' Health Study cohorts. BMJ. 2013 Nov 14; 347:f6633. PMID: 24231178; PMCID: PMC3935281.
  107. Xia Z, Secor E, Chibnik LB, Bove RM, Cheng S, Chitnis T, Cagan A, Gainer VS, Chen PJ, Liao KP, Shaw SY, Ananthakrishnan AN, Szolovits P, Weiner HL, Karlson EW, Murphy SN, Savova GK, Cai T, Churchill SE, Plenge RM, Kohane IS, De Jager PL. Modeling disease severity in multiple sclerosis using electronic health records. PLoS One. 2013; 8(11):e78927. PMID: 24244385; PMCID: PMC3823928.
  108. Ananthakrishnan AN, Cheng SC, Cai T, Cagan A, Gainer VS, Szolovits P, Shaw SY, Churchill S, Karlson EW, Murphy SN, Kohane I, Liao KP. Association between reduced plasma 25-hydroxy vitamin D and increased risk of cancer in patients with inflammatory bowel diseases. Clin Gastroenterol Hepatol. 2014 May; 12(5):821-7. PMID: 24161349; PMCID: PMC3995841.
  109. Zator ZA, Cantu SM, Konijeti GG, Nguyen DD, Sauk J, Yajnik V, Ananthakrishnan AN. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-a therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr. 2014 Mar-Apr; 38(3):385-91. PMID: 24088707.
    View in: PubMed
  110. Perera LP, Ananthakrishnan AN, Guilday C, Remshak K, Zadvornova Y, Naik AS, Stein DJ, Massey BT. Dyssynergic defecation: a treatable cause of persistent symptoms when inflammatory bowel disease is in remission. Dig Dis Sci. 2013 Dec; 58(12):3600-5. PMID: 24026401.
    View in: PubMed
  111. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Korzenik JR, Fuchs CS, Willett WC, Richter JM, Chan AT. A prospective study of long-term intake of dietary fiber and risk of Crohn's disease and ulcerative colitis. Gastroenterology. 2013 Nov; 145(5):970-7. PMID: 23912083; PMCID: PMC3805714.
  112. Ananthakrishnan AN, Cagan A, Gainer VS, Cai T, Cheng SC, Savova G, Chen P, Szolovits P, Xia Z, De Jager PL, Shaw SY, Churchill S, Karlson EW, Kohane I, Plenge RM, Murphy SN, Liao KP. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis. 2013 Aug; 19(9):1921-7. PMID: 23751398; PMCID: PMC3720838.
  113. Ananthakrishnan AN. Personalizing therapy for inflammatory bowel diseases. Expert Rev Gastroenterol Hepatol. 2013 Aug; 7(6):549-58. PMID: 23985004.
    View in: PubMed
  114. Ananthakrishnan AN, Xavier RJ. How does genotype influence disease phenotype in inflammatory bowel disease? Inflamm Bowel Dis. 2013 Aug; 19(9):2021-30. PMID: 23644824; PMCID: PMC3720704.
  115. Ananthakrishnan AN, Oxford EC, Nguyen DD, Sauk J, Yajnik V, Xavier RJ. Genetic risk factors for Clostridium difficile infection in ulcerative colitis. Aliment Pharmacol Ther. 2013 Sep; 38(5):522-30. PMID: 23848254; PMCID: PMC3755009.
  116. Ananthakrishnan AN, Khalili H, Konijeti GG, Higuchi LM, de Silva P, Fuchs CS, Willett WC, Richter JM, Chan AT. Long-term intake of dietary fat and risk of ulcerative colitis and Crohn's disease. Gut. 2014 May; 63(5):776-84. PMID: 23828881; PMCID: PMC3915038.
  117. Ananthakrishnan AN, Cai T, Savova G, Cheng SC, Chen P, Perez RG, Gainer VS, Murphy SN, Szolovits P, Xia Z, Shaw S, Churchill S, Karlson EW, Kohane I, Plenge RM, Liao KP. Improving case definition of Crohn's disease and ulcerative colitis in electronic medical records using natural language processing: a novel informatics approach. Inflamm Bowel Dis. 2013 Jun; 19(7):1411-20. PMID: 23567779; PMCID: PMC3665760.
  118. Ananthakrishnan AN. Environmental risk factors for inflammatory bowel disease. Gastroenterol Hepatol (N Y). 2013 Jun; 9(6):367-74. PMID: 23935543; PMCID: PMC3736793.
  119. Liao KP, Diogo D, Cui J, Cai T, Okada Y, Gainer VS, Murphy SN, Gupta N, Mirel D, Ananthakrishnan AN, Szolovits P, Shaw SY, Raychaudhuri S, Churchill S, Kohane I, Karlson EW, Plenge RM. Association between low density lipoprotein and rheumatoid arthritis genetic factors with low density lipoprotein levels in rheumatoid arthritis and non-rheumatoid arthritis controls. Ann Rheum Dis. 2014 Jun; 73(6):1170-5. PMID: 23716066; PMCID: PMC3815491.
  120. Ananthakrishnan AN. Antibiotic exposure is associated with development of inflammatory bowel disease. J Pediatr. 2013 May; 162(5):1077. PMID: 23617975.
    View in: PubMed
  121. Sauk J, Coron E, Kava L, Suter M, Gora M, Gallagher K, Rosenberg M, Ananthakrishnan A, Nishioka N, Lauwers G, Woods K, Brugge W, Forcione D, Bouma BE, Tearney G. Interobserver agreement for the detection of Barrett's esophagus with optical frequency domain imaging. Dig Dis Sci. 2013 Aug; 58(8):2261-5. PMID: 23508980; PMCID: PMC3732518.
  122. Ananthakrishnan AN, McGinley EL. Weekend hospitalisations and post-operative complications following urgent surgery for ulcerative colitis and Crohn's disease. Aliment Pharmacol Ther. 2013 May; 37(9):895-904. PMID: 23451882; PMCID: PMC3618593.
  123. Khalili H, Ananthakrishnan AN, Higuchi LM, Richter JM, Fuchs CS, Chan AT. Early life factors and risk of inflammatory bowel disease in adulthood. Inflamm Bowel Dis. 2013 Mar; 19(3):542-7. PMID: 23429446; PMCID: PMC3712531.
  124. Surawicz CM, Brandt LJ, Binion DG, Ananthakrishnan AN, Curry SR, Gilligan PH, McFarland LV, Mellow M, Zuckerbraun BS. Guidelines for diagnosis, treatment, and prevention of Clostridium difficile infections. Am J Gastroenterol. 2013 Apr; 108(4):478-98; quiz 499. PMID: 23439232.
    View in: PubMed
  125. Oxford EC, Nguyen DD, Sauk J, Korzenik JR, Yajnik V, Friedman S, Ananthakrishnan AN. Impact of coexistent celiac disease on phenotype and natural history of inflammatory bowel diseases. Am J Gastroenterol. 2013 Jul; 108(7):1123-9. PMID: 23419379; PMCID: PMC3845216.
  126. Ananthakrishnan AN, McGinley EL. Treatment of intra-abdominal abscesses in Crohn's disease: a nationwide analysis of patterns and outcomes of care. Dig Dis Sci. 2013 Jul; 58(7):2013-8. PMID: 23392744; PMCID: PMC3663922.
  127. Ananthakrishnan AN, Long MD, Martin CF, Sandler RS, Kappelman MD. Sleep disturbance and risk of active disease in patients with Crohn's disease and ulcerative colitis. Clin Gastroenterol Hepatol. 2013 Aug; 11(8):965-71. PMID: 23376797; PMCID: PMC3659204.
  128. Desai A, Zator ZA, de Silva P, Nguyen DD, Korzenik J, Yajnik V, Ananthakrishnan AN. Older age is associated with higher rate of discontinuation of anti-TNF therapy in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2013 Feb; 19(2):309-15. PMID: 22605668; PMCID: PMC4345352.
  129. Ananthakrishnan AN, Gainer VS, Cai T, Perez RG, Cheng SC, Savova G, Chen P, Szolovits P, Xia Z, De Jager PL, Shaw S, Churchill S, Karlson EW, Kohane I, Perlis RH, Plenge RM, Murphy SN, Liao KP. Similar risk of depression and anxiety following surgery or hospitalization for Crohn's disease and ulcerative colitis. Am J Gastroenterol. 2013 Apr; 108(4):594-601. PMID: 23337479; PMCID: PMC3627544.
  130. Ananthakrishnan AN, Gainer VS, Perez RG, Cai T, Cheng SC, Savova G, Chen P, Szolovits P, Xia Z, De Jager PL, Shaw SY, Churchill S, Karlson EW, Kohane I, Perlis RH, Plenge RM, Murphy SN, Liao KP. Psychiatric co-morbidity is associated with increased risk of surgery in Crohn's disease. Aliment Pharmacol Ther. 2013 Feb; 37(4):445-54. PMID: 23289600; PMCID: PMC3552092.
  131. Ananthakrishnan AN, Korzenik JR, Hur C. Can mucosal healing be a cost-effective endpoint for biologic therapy in Crohn's disease? A decision analysis. Inflamm Bowel Dis. 2013 Jan; 19(1):37-44. PMID: 22416019.
    View in: PubMed
  132. Ananthakrishnan AN. Environmental triggers for inflammatory bowel disease. Curr Gastroenterol Rep. 2013 Jan; 15(1):302. PMID: 23250702; PMCID: PMC3537164.
  133. Jostins L, Ripke S, Weersma RK, Duerr RH, McGovern DP, Hui KY, Lee JC, Schumm LP, Sharma Y, Anderson CA, Essers J, Mitrovic M, Ning K, Cleynen I, Theatre E, Spain SL, Raychaudhuri S, Goyette P, Wei Z, Abraham C, Achkar JP, Ahmad T, Amininejad L, Ananthakrishnan AN, Andersen V, Andrews JM, Baidoo L, Balschun T, Bampton PA, Bitton A, Boucher G, Brand S, Büning C, Cohain A, Cichon S, D'Amato M, De Jong D, Devaney KL, Dubinsky M, Edwards C, Ellinghaus D, Ferguson LR, Franchimont D, Fransen K, Gearry R, Georges M, Gieger C, Glas J, Haritunians T, Hart A, Hawkey C, Hedl M, Hu X, Karlsen TH, Kupcinskas L, Kugathasan S, Latiano A, Laukens D, Lawrance IC, Lees CW, Louis E, Mahy G, Mansfield J, Morgan AR, Mowat C, Newman W, Palmieri O, Ponsioen CY, Potocnik U, Prescott NJ, Regueiro M, Rotter JI, Russell RK, Sanderson JD, Sans M, Satsangi J, Schreiber S, Simms LA, Sventoraityte J, Targan SR, Taylor KD, Tremelling M, Verspaget HW, De Vos M, Wijmenga C, Wilson DC, Winkelmann J, Xavier RJ, Zeissig S, Zhang B, Zhang CK, Zhao H, Silverberg MS, Annese V, Hakonarson H, Brant SR, Radford-Smith G, Mathew CG, Rioux JD, Schadt EE, Daly MJ, Franke A, Parkes M, Vermeire S, Barrett JC, Cho JH. Host-microbe interactions have shaped the genetic architecture of inflammatory bowel disease. Nature. 2012 Nov 01; 491(7422):119-24. PMID: 23128233; PMCID: PMC3491803.
  134. Ananthakrishnan AN, Zadvornova Y, Naik AS, Issa M, Perera LP. Impact of pregnancy on health-related quality of life of patients with inflammatory bowel disease. J Dig Dis. 2012 Sep; 13(9):472-7. PMID: 22908973.
    View in: PubMed
  135. Ananthakrishnan AN, Khalili H, Pan A, Higuchi LM, de Silva P, Richter JM, Fuchs CS, Chan AT. Association between depressive symptoms and incidence of Crohn's disease and ulcerative colitis: results from the Nurses' Health Study. Clin Gastroenterol Hepatol. 2013 Jan; 11(1):57-62. PMID: 22944733; PMCID: PMC3587728.
  136. Ali M, Ananthakrishnan AN, Ahmad S, Kumar N, Kumar G, Saeian K. Clostridium difficile infection in hospitalized liver transplant patients: a nationwide analysis. Liver Transpl. 2012 Aug; 18(8):972-8. PMID: 22505356; PMCID: PMC3405162.
  137. Ananthakrishnan AN, Chan AT. Reply. Gastroenterology. 2012 Sep; 143(3):e28-9. PMID: 22841508.
    View in: PubMed
  138. Khalili H, Higuchi LM, Ananthakrishnan AN, Manson JE, Feskanich D, Richter JM, Fuchs CS, Chan AT. Hormone therapy increases risk of ulcerative colitis but not Crohn's disease. Gastroenterology. 2012 Nov; 143(5):1199-206. PMID: 22841783; PMCID: PMC3480540.
  139. de Silva PS, Nguyen DD, Sauk J, Korzenik J, Yajnik V, Ananthakrishnan AN. Long-term outcome of a third anti-TNF monoclonal antibody after the failure of two prior anti-TNFs in inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Sep; 36(5):459-66. PMID: 22784296.
    View in: PubMed
  140. Axelrad JE, Fowler SA, Friedman S, Ananthakrishnan AN, Yajnik V. Effects of cancer treatment on inflammatory bowel disease remission and reactivation. Clin Gastroenterol Hepatol. 2012 Sep; 10(9):1021-7.e1. PMID: 22732273.
    View in: PubMed
  141. Juillerat P, Schneeweiss S, Cook EF, Ananthakrishnan AN, Mogun H, Korzenik JR. Drugs that inhibit gastric acid secretion may alter the course of inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Aug; 36(3):239-47. PMID: 22670722.
    View in: PubMed
  142. Kumar N, Bashar Q, Reddy N, Sengupta J, Ananthakrishnan A, Schroeder A, Hogan WJ, Venkatesan T. Cyclic Vomiting Syndrome (CVS): is there a difference based on onset of symptoms--pediatric versus adult? BMC Gastroenterol. 2012 May 28; 12:52. PMID: 22639867; PMCID: PMC3443054.
  143. Khalili H, Higuchi LM, Ananthakrishnan AN, Richter JM, Feskanich D, Fuchs CS, Chan AT. Oral contraceptives, reproductive factors and risk of inflammatory bowel disease. Gut. 2013 Aug; 62(8):1153-9. PMID: 22619368; PMCID: PMC3465475.
  144. Ananthakrishnan AN. Reply to Dr. McNabb-Baltar's letter. J Crohns Colitis. 2012 Sep; 6(8):868. PMID: 22591728.
    View in: PubMed
  145. Ananthakrishnan AN, McGinley EL. Infection-related hospitalizations are associated with increased mortality in patients with inflammatory bowel diseases. J Crohns Colitis. 2013 Mar; 7(2):107-12. PMID: 22440891.
    View in: PubMed
  146. Omer ZB, Ananthakrishnan AN, Nattinger KJ, Cole EB, Lin JJ, Kong CY, Hur C. Aspirin protects against Barrett's esophagus in a multivariate logistic regression analysis. Clin Gastroenterol Hepatol. 2012 Jul; 10(7):722-7. PMID: 22426086; PMCID: PMC3435144.
  147. Ananthakrishnan AN, Higuchi LM, Huang ES, Khalili H, Richter JM, Fuchs CS, Chan AT. Aspirin, nonsteroidal anti-inflammatory drug use, and risk for Crohn disease and ulcerative colitis: a cohort study. Ann Intern Med. 2012 Mar 06; 156(5):350-9. PMID: 22393130; PMCID: PMC3369539.
  148. Ananthakrishnan AN, Guzman-Perez R, Gainer V, Cai T, Churchill S, Kohane I, Plenge RM, Murphy S. Predictors of severe outcomes associated with Clostridium difficile infection in patients with inflammatory bowel disease. Aliment Pharmacol Ther. 2012 Apr; 35(7):789-95. PMID: 22360370; PMCID: PMC3716251.
  149. Ananthakrishnan AN. Detecting and treating Clostridium difficile infections in patients with inflammatory bowel disease. Gastroenterol Clin North Am. 2012 Jun; 41(2):339-53. PMID: 22500522.
    View in: PubMed
  150. Khalili H, Huang ES, Ananthakrishnan AN, Higuchi L, Richter JM, Fuchs CS, Chan AT. Geographical variation and incidence of inflammatory bowel disease among US women. Gut. 2012 Dec; 61(12):1686-92. PMID: 22241842; PMCID: PMC3418414.
  151. De Silva P, Ananthakrishnan AN. Vitamin D and IBD: more pieces to the puzzle, still no complete picture. Inflamm Bowel Dis. 2012 Jul; 18(7):1391-3. PMID: 22180018.
    View in: PubMed
  152. Ananthakrishnan AN, Khalili H, Higuchi LM, Bao Y, Korzenik JR, Giovannucci EL, Richter JM, Fuchs CS, Chan AT. Higher predicted vitamin D status is associated with reduced risk of Crohn's disease. Gastroenterology. 2012 Mar; 142(3):482-9. PMID: 22155183; PMCID: PMC3367959.
  153. Ananthakrishnan AN, Hur C, Korzenik JR. Certolizumab pegol compared to natalizumab in patients with moderate to severe Crohn's disease: results of a decision analysis. Dig Dis Sci. 2012 Feb; 57(2):472-80. PMID: 21909990.
    View in: PubMed
  154. Ananthakrishnan AN, Chan AT. Missed polyps, missed opportunities. Gastrointest Endosc. 2011 Aug; 74(2):262-5. PMID: 21802584.
    View in: PubMed
  155. Ananthakrishnan AN, Hur C, Juillerat P, Korzenik JR. Strategies for the prevention of postoperative recurrence in Crohn's disease: results of a decision analysis. Am J Gastroenterol. 2011 Nov; 106(11):2009-17. PMID: 21788991.
    View in: PubMed
  156. Ulitsky A, Ananthakrishnan AN, Naik A, Skaros S, Zadvornova Y, Binion DG, Issa M. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr. 2011 May; 35(3):308-16. PMID: 21527593.
    View in: PubMed
  157. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Physician density and hospitalization for inflammatory bowel disease. Inflamm Bowel Dis. 2011 Feb; 17(2):633-8. PMID: 20848540.
    View in: PubMed
  158. Ali M, Ananthakrishnan AN, McGinley EL, Saeian K. Deep vein thrombosis and pulmonary embolism in hospitalized patients with cirrhosis: a nationwide analysis. Dig Dis Sci. 2011 Jul; 56(7):2152-9. PMID: 21279685.
    View in: PubMed
  159. Qumseya BJ, Ananthakrishnan AN, Skaros S, Bonner M, Issa M, Zadvornova Y, Naik A, Perera L, Binion DG. QuantiFERON TB gold testing for tuberculosis screening in an inflammatory bowel disease cohort in the United States. Inflamm Bowel Dis. 2011 Jan; 17(1):77-83. PMID: 20848501.
    View in: PubMed
  160. Venkatesan T, Prieto T, Barboi A, Li B, Schroeder A, Hogan W, Ananthakrishnan A, Jaradeh S. Autonomic nerve function in adults with cyclic vomiting syndrome: a prospective study. Neurogastroenterol Motil. 2010 Dec; 22(12):1303-7, e339. PMID: 20667005.
    View in: PubMed
  161. Ananthakrishnan AN. Clostridium difficile infection: epidemiology, risk factors and management. Nat Rev Gastroenterol Hepatol. 2011 Jan; 8(1):17-26. PMID: 21119612.
    View in: PubMed
  162. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. A nationwide analysis of changes in severity and outcomes of inflammatory bowel disease hospitalizations. J Gastrointest Surg. 2011 Feb; 15(2):267-76. PMID: 21108015.
    View in: PubMed
  163. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Fracture-associated hospitalizations in patients with inflammatory bowel disease. Dig Dis Sci. 2011 Jan; 56(1):176-82. PMID: 20936351.
    View in: PubMed
  164. Ananthakrishnan AN, McGinley EL, Fangman J, Saeian K. Hepatitis C/HIV co-infection is associated with higher mortality in hospitalized patients with hepatitis C or HIV. J Viral Hepat. 2010 Oct; 17(10):720-9. PMID: 20002558.
    View in: PubMed
  165. Ananthakrishnan AN, Binion DG. Impact of Clostridium difficile on inflammatory bowel disease. Expert Rev Gastroenterol Hepatol. 2010 Oct; 4(5):589-600. PMID: 20932144.
    View in: PubMed
  166. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Temporal trends in disease outcomes related to Clostridium difficile infection in patients with inflammatory bowel disease. Inflamm Bowel Dis. 2011 Apr; 17(4):976-83. PMID: 20824818.
    View in: PubMed
  167. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Simple score to identify colectomy risk in ulcerative colitis hospitalizations. Inflamm Bowel Dis. 2010 Sep; 16(9):1532-40. PMID: 20091926.
    View in: PubMed
  168. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. Ambient air pollution correlates with hospitalizations for inflammatory bowel disease: an ecologic analysis. Inflamm Bowel Dis. 2011 May; 17(5):1138-45. PMID: 20806342.
    View in: PubMed
  169. Ananthakrishnan AN, McGinley EL, Saeian K. Length of office visits for gastrointestinal disease: impact of physician specialty. Am J Gastroenterol. 2010 Aug; 105(8):1719-25. PMID: 20686459.
    View in: PubMed
  170. Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease: more questions than answers? Inflamm Bowel Dis. 2010 Aug; 16(8):1445-6. PMID: 19827137.
    View in: PubMed
  171. Ananthakrishnan AN, Hoffmann RG, Saeian K. Higher physician density is associated with lower incidence of late-stage colorectal cancer. J Gen Intern Med. 2010 Nov; 25(11):1164-71. PMID: 20658268; PMCID: PMC2947641.
  172. Stein DJ, Ananthakrishnan AN, Issa M, Williams JB, Beaulieu DB, Zadvornova Y, Ward A, Johnson K, Knox JF, Skaros S, Binion DG. Impact of prior irregular infliximab dosing on performance of long-term infliximab maintenance therapy in Crohn's disease. Inflamm Bowel Dis. 2010 Jul; 16(7):1173-9. PMID: 19924800.
    View in: PubMed
  173. Ananthakrishnan AN, Binion DG. Editorial: improved efficacy of biological maintenance therapy in "early" compared with "late" Crohn's disease: strike while the iron is hot with anti-TNF agents? Am J Gastroenterol. 2010 Jul; 105(7):1583-5. PMID: 20606661.
    View in: PubMed
  174. Ulitsky A, Ananthakrishnan AN, Komorowski R, Wallace J, Surapaneni SN, Franco J, Saeian K, Gawrieh S. A noninvasive clinical scoring model predicts risk of nonalcoholic steatohepatitis in morbidly obese patients. Obes Surg. 2010 Jun; 20(6):685-91. PMID: 20336392.
    View in: PubMed
  175. Ananthakrishnan AN, Issa M, Barboi A, Jaradeh S, Zadvornova Y, Skaros S, Johnson K, Otterson MF, Binion DG. Impact of autonomic dysfunction on inflammatory bowel disease. J Clin Gastroenterol. 2010 Apr; 44(4):272-9. PMID: 19727003.
    View in: PubMed
  176. Bilgi N, Bell K, Ananthakrishnan AN, Atallah E. Imatinib and Panax ginseng: a potential interaction resulting in liver toxicity. Ann Pharmacother. 2010 May; 44(5):926-8. PMID: 20332334.
    View in: PubMed
  177. Ananthakrishnan AN, McGinley EL, Binion DG, Saeian K. A novel risk score to stratify severity of Crohn's disease hospitalizations. Am J Gastroenterol. 2010 Aug; 105(8):1799-807. PMID: 20216534.
    View in: PubMed
  178. Ananthakrishnan AN, Beaulieu DB, Ulitsky A, Zadvornova Y, Skaros S, Johnson K, Naik A, Perera L, Issa M, Binion DG, Saeian K. Does primary sclerosing cholangitis impact quality of life in patients with inflammatory bowel disease? Inflamm Bowel Dis. 2010 Mar; 16(3):494-500. PMID: 19637332.
    View in: PubMed
  179. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Med Clin North Am. 2010 Jan; 94(1):135-53. PMID: 19944802.
    View in: PubMed
  180. Ananthakrishnan AN, Issa M, Binion DG. Clostridium difficile and inflammatory bowel disease. Gastroenterol Clin North Am. 2009 Dec; 38(4):711-28. PMID: 19913210.
    View in: PubMed
  181. Bajaj JS, Ananthakrishnan AN, Hafeezullah M, Zadvornova Y, Dye A, McGinley EL, Saeian K, Heuman D, Sanyal AJ, Hoffmann RG. Clostridium difficile is associated with poor outcomes in patients with cirrhosis: A national and tertiary center perspective. Am J Gastroenterol. 2010 Jan; 105(1):106-13. PMID: 19844204.
    View in: PubMed
  182. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Trends in ambulatory and emergency room visits for inflammatory bowel diseases in the United States: 1994-2005. Am J Gastroenterol. 2010 Feb; 105(2):363-70. PMID: 19809414.
    View in: PubMed
  183. Ananthakrishnan AN, Binion DG. Treatment of ulcerative colitis in the elderly. Dig Dis. 2009; 27(3):327-34. PMID: 19786760.
    View in: PubMed
  184. Ananthakrishnan AN, McGinley EL, Saeian K, Binion DG. Laparoscopic resection for inflammatory bowel disease: outcomes from a nationwide sample. J Gastrointest Surg. 2010 Jan; 14(1):58-65. PMID: 19760371.
    View in: PubMed
  185. Ananthakrishnan AN, McGinley EL, Saeian K. Higher hospital volume is associated with lower mortality in acute nonvariceal upper-GI hemorrhage. Gastrointest Endosc. 2009 Sep; 70(3):422-32. PMID: 19560760.
    View in: PubMed
  186. Gonzaga JE, Ananthakrishnan AN, Issa M, Beaulieu DB, Skaros S, Zadvornova Y, Johnson K, Otterson MF, Binion DG. Durability of infliximab in Crohn's disease: a single-center experience. Inflamm Bowel Dis. 2009 Dec; 15(12):1837-43. PMID: 19462426.
    View in: PubMed
  187. Ananthakrishnan AN, McGinley EL, Binion DG. Inflammatory bowel disease in the elderly is associated with worse outcomes: a national study of hospitalizations. Inflamm Bowel Dis. 2009 Feb; 15(2):182-9. PMID: 18668678.
    View in: PubMed
  188. Ananthakrishnan AN, Issa M, Beaulieu DB, Skaros S, Knox JF, Lemke K, Emmons J, Lundeen SH, Otterson MF, Binion DG. History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis. Inflamm Bowel Dis. 2009 Feb; 15(2):176-81. PMID: 18680197.
    View in: PubMed
  189. Beaulieu DB, Ananthakrishnan AN, Issa M, Rosenbaum L, Skaros S, Newcomer JR, Kuhlmann RS, Otterson MF, Emmons J, Knox J, Binion DG. Budesonide induction and maintenance therapy for Crohn's disease during pregnancy. Inflamm Bowel Dis. 2009 Jan; 15(1):25-8. PMID: 18680195.
    View in: PubMed
  190. Ananthakrishnan AN, McGinley EL, Saeian K. Higher hospital volume predicts endoscopy but not the in-hospital mortality rate in patients with acute variceal hemorrhage. Gastrointest Endosc. 2009 Feb; 69(2):221-9. PMID: 18950765.
    View in: PubMed
  191. Issa M, Ananthakrishnan AN, Binion DG. Clostridium difficile and inflammatory bowel disease. Inflamm Bowel Dis. 2008 Oct; 14(10):1432-42. PMID: 18484669.
    View in: PubMed
  192. Ananthakrishnan AN, McGinley EL, Saeian K. Effect of hospital volume and teaching status on outcomes of acute liver failure. Liver Transpl. 2008 Sep; 14(9):1347-56. PMID: 18756487.
    View in: PubMed
  193. Ananthakrishnan AN, McGinley EL, Saeian K. Outcomes of weekend admissions for upper gastrointestinal hemorrhage: a nationwide analysis. Clin Gastroenterol Hepatol. 2009 Mar; 7(3):296-302e1. PMID: 19084483.
    View in: PubMed
  194. Ananthakrishnan AN, McGinley EL, Binion DG. Does it matter where you are hospitalized for inflammatory bowel disease? A nationwide analysis of hospital volume. Am J Gastroenterol. 2008 Nov; 103(11):2789-98. PMID: 18684184.
    View in: PubMed
  195. Bajaj JS, Ananthakrishnan AN, McGinley EL, Hoffmann RG, Brasel KJ. Deleterious effect of cirrhosis on outcomes after motor vehicle crashes using the nationwide inpatient sample. Am J Gastroenterol. 2008 Jul; 103(7):1674-81. PMID: 18616657.
    View in: PubMed
  196. Ananthakrishnan AN, Saeian K. Racial differences in liver transplantation outcomes in the MELD era. Am J Gastroenterol. 2008 Apr; 103(4):901-10. PMID: 18371131.
    View in: PubMed
  197. Ananthakrishnan AN, Weber LR, Knox JF, Skaros S, Emmons J, Lundeen S, Issa M, Otterson MF, Binion DG. Permanent work disability in Crohn's disease. Am J Gastroenterol. 2008 Jan; 103(1):154-61. PMID: 18076736.
    View in: PubMed
  198. Ananthakrishnan AN, McGinley EL, Binion DG. Excess hospitalisation burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut. 2008 Feb; 57(2):205-10. PMID: 17905821.
    View in: PubMed
  199. Ananthakrishnan AN, Attila T, Otterson MF, Lipchik RJ, Massey BT, Komorowski RA, Binion DG. Severe pulmonary toxicity after azathioprine/6-mercaptopurine initiation for the treatment of inflammatory bowel disease. J Clin Gastroenterol. 2007 Aug; 41(7):682-8. PMID: 17667053.
    View in: PubMed
  200. Ananthakrishnan AN, Saeian K. Caroli's disease: identification and treatment strategy. Curr Gastroenterol Rep. 2007 Apr; 9(2):151-5. PMID: 17418061.
    View in: PubMed
  201. Ananthakrishnan AN, Schellhase KG, Sparapani RA, Laud PW, Neuner JM. Disparities in colon cancer screening in the Medicare population. Arch Intern Med. 2007 Feb 12; 167(3):258-64. PMID: 17296881.
    View in: PubMed
  202. Yadav MR, Nimekar DM, Ananthakrishnan A, Brahmkshatriya PS, Shirude ST, Giridhar R, Parmar A, Balaraman R. Synthesis of new chemical entities from paracetamol and NSAIDs with improved pharmacodynamic profile. Bioorg Med Chem. 2006 Dec 15; 14(24):8701-6. PMID: 16962330.
    View in: PubMed
  203. Jittiwutikarn J, Thongsawat S, Suriyanon V, Maneekarn N, Celentano D, Razak MH, Srirak N, Vongchak T, Kawichai S, Thomas D, Sripaipan T, Netski D, Ananthakrishnan A, Nelson KE. Hepatitis C infection among drug users in northern Thailand. Am J Trop Med Hyg. 2006 Jun; 74(6):1111-6. PMID: 16760529.
    View in: PubMed
  204. Ananthakrishnan A, Gogineni V, Saeian K. Epidemiology of primary and secondary liver cancers. Semin Intervent Radiol. 2006 Mar; 23(1):47-63. PMID: 21326720; PMCID: PMC3036307.
  205. Bajaj JS, Ananthakrishnan A, Saeian K. Survey of attitudes of AASLD members toward balloon tamponade. Hepatology. 2005 Jun; 41(6):1435-6. PMID: 15915472.
    View in: PubMed
  206. Shanmuganathan C, Ananthakrishnan A, Jayakeerthi SR, Kanungo R, Kumar A, Bhattacharya S, Badrinath S. Learning from an outbreak: ESBL- the essential points. Indian J Med Microbiol. 2004 Oct-Dec; 22(4):255-7. PMID: 17642750.
    View in: PubMed
Local representatives can answer questions about the Profiles website or help with editing a profile or issues with profile data. For assistance with this profile: HMS/HSDM faculty should contact feedbackcatalyst.harvard.edu. For demographic and contact information changes only, HMS/HSDM faculty should contact Human Resources at human_resourceshms.harvard.edu.
Ananthakrishnan's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_